SV2002000201A - Un estuche de combinacion usado en el tratamiento del paludismo ref. ftll/198 - Google Patents

Un estuche de combinacion usado en el tratamiento del paludismo ref. ftll/198

Info

Publication number
SV2002000201A
SV2002000201A SV2000000201A SV2000000201A SV2002000201A SV 2002000201 A SV2002000201 A SV 2002000201A SV 2000000201 A SV2000000201 A SV 2000000201A SV 2000000201 A SV2000000201 A SV 2000000201A SV 2002000201 A SV2002000201 A SV 2002000201A
Authority
SV
El Salvador
Prior art keywords
treatment
amino
paludism
combination case
antipaludic
Prior art date
Application number
SV2000000201A
Other languages
English (en)
Spanish (es)
Inventor
Francis Joseph Pinto
Swati Ajay Piramal
Ram Pratap
Bhaduri Amiya Prasad
Harsh Pati Thapliyal
Puri Sunil Kumar
Dutta Guru Prasad
Dwivedi Anil Kumar
Satyawan Singh
Pratima Srivastava
Vikash Chandra Pandey
Sudhir Srivastava
Singh Shio Kumar
Ram Chandra Gupta
Srivastava Jagdishwar Sahai
Asthana Omkar Prasad
Original Assignee
Nicholas Piramal India Ltd
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd, Council Scient Ind Res filed Critical Nicholas Piramal India Ltd
Publication of SV2002000201A publication Critical patent/SV2002000201A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47064-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
SV2000000201A 2000-05-31 2000-10-13 Un estuche de combinacion usado en el tratamiento del paludismo ref. ftll/198 SV2002000201A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN501MU2000 2000-05-31

Publications (1)

Publication Number Publication Date
SV2002000201A true SV2002000201A (es) 2002-10-24

Family

ID=11097250

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2000000201A SV2002000201A (es) 2000-05-31 2000-10-13 Un estuche de combinacion usado en el tratamiento del paludismo ref. ftll/198

Country Status (28)

Country Link
US (1) US7404962B1 (https=)
EP (1) EP1292306B1 (https=)
JP (1) JP2004505017A (https=)
KR (1) KR20030025926A (https=)
AP (1) AP1435A (https=)
AR (1) AR028458A1 (https=)
AT (1) ATE314848T1 (https=)
AU (2) AU2879001A (https=)
BR (1) BR0005247A (https=)
CA (1) CA2413775C (https=)
CR (1) CR6835A (https=)
CZ (1) CZ296875B6 (https=)
DE (2) DE60025403T2 (https=)
DK (1) DK1292306T3 (https=)
EC (1) ECSP003694A (https=)
ES (1) ES2200729T3 (https=)
GT (1) GT200000187A (https=)
HK (1) HK1052467B (https=)
HN (1) HN2001000118A (https=)
HU (1) HUP0301925A3 (https=)
MX (1) MXPA02011883A (https=)
NO (1) NO324774B1 (https=)
OA (1) OA12276A (https=)
PE (1) PE20011319A1 (https=)
PL (1) PL200748B1 (https=)
SV (1) SV2002000201A (https=)
WO (1) WO2001091535A2 (https=)
ZA (1) ZA200209726B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008135762A (ru) * 2006-02-16 2010-03-27 Де МакЛин Хоспитал Корпорейшн (US) Способы и композиции для лечения болезни паркинсона
US8658648B2 (en) 2008-12-05 2014-02-25 Designmedix, Inc. Modified chloroquines with single ring moiety or fused ring moiety
WO2010144102A1 (en) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Material Command Pentafluorosulfanyl analogs of mefloquine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5270037A (en) * 1990-07-12 1993-12-14 Boehringer Ingelheim Gmbh Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
WO1993015727A1 (en) * 1992-02-07 1993-08-19 Ciba-Geigy Ag Antimalarial synergistic compositions containing benflumetol

Also Published As

Publication number Publication date
DE60025403T2 (de) 2006-08-24
ES2200729T3 (es) 2006-07-16
PE20011319A1 (es) 2002-03-02
AU2001228790B2 (en) 2007-02-01
DE60025403D1 (de) 2006-03-30
MXPA02011883A (es) 2004-05-17
HUP0301925A2 (hu) 2003-09-29
NO324774B1 (no) 2007-12-10
NO20025765L (no) 2003-01-08
CA2413775C (en) 2009-08-25
ECSP003694A (es) 2002-01-25
ES2200729T1 (es) 2004-03-16
CR6835A (es) 2007-04-26
GT200000187A (es) 2002-04-18
BR0005247A (pt) 2002-02-13
AR028458A1 (es) 2003-05-07
ZA200209726B (en) 2004-03-10
AU2879001A (en) 2001-12-11
DE00993875T1 (de) 2004-04-15
CA2413775A1 (en) 2001-12-06
CZ296875B6 (cs) 2006-07-12
HUP0301925A3 (en) 2009-03-30
JP2004505017A (ja) 2004-02-19
AP2002002672A0 (en) 2002-12-31
OA12276A (en) 2006-05-10
PL372718A1 (en) 2005-07-25
CZ20024071A3 (cs) 2003-04-16
DK1292306T3 (da) 2006-05-22
WO2001091535A2 (en) 2001-12-06
AP1435A (en) 2005-06-21
EP1292306B1 (en) 2006-01-04
PL200748B1 (pl) 2009-02-27
ATE314848T1 (de) 2006-02-15
HN2001000118A (es) 2001-10-29
WO2001091535B1 (en) 2002-10-31
WO2001091535A3 (en) 2002-07-04
US7404962B1 (en) 2008-07-29
HK1052467A1 (en) 2003-09-19
KR20030025926A (ko) 2003-03-29
HK1052467B (en) 2006-03-10
NO20025765D0 (no) 2002-11-29
EP1292306A2 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
CO5700707A2 (es) Productos farmaceuticos
AR025962A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que los contienen
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
AR024966A1 (es) Formulacion farmaceutica
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
ES2091173T1 (es) Nueva composicion farmaceutica que contiene el inhibidor de ace ramipril y un compuesto de dihidropiridina.
UY26439A1 (es) Nueva composición y uso
ES2157881T3 (es) Metanosulfonato de paroxetina.
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
SE9600072D0 (sv) New oral formulation of two active ingredients II
CO5611097A2 (es) Tableta farmaceutica
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
CO5540373A2 (es) Composicion farmaceutica de liberacion sostenida
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
CO5070571A1 (es) Preparado farmaceutico de moxifloxacina
AR046970A1 (es) Esteres de fosfato de florfenicol
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
CO5200840A1 (es) Combinacion de sustancias activas con clonidina
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
PA8523101A1 (es) Composicion de eletriptan en forma de particulas